Mapping of endogenous morphine-like compounds in the adult mouse brain: Evidence of their localization in astrocytes and GABAergic cells

Journal of Comparative Neurology

Volumn 519, Issue 12, 2011, Pages 2390-2416

  Laux, Alexis ^a,b   Muller, Arnaud H ^b   Miehe, Monique ^a,c   Dirrig Grosch, Sylvie ^d   Deloulme, Jean Christophe ^e   Delalande, François ^d   Stuber, Denise ^a   Sage, Dominique ^c   Van Dorsselaer, Alain ^d   Poisbeau, Pierrick ^a   Aunis, Dominique ^b   Goumon, Yannick ^a,b  

^a Institut des Neurosciences Cellulaires et Intégratives UPR3212   (France)

^b INSERM   (France)

^c Centre de Neurochimie   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

Author keywords

Codeine; Dopamine; Immunohistochemistry; Morphine; Morphine 3 glucuronide; Morphine 6 glucuronide

Indexed keywords

CODEINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; ASTROCYTE; BASAL GANGLION; CELLULAR DISTRIBUTION; CEREBELLUM; CONTROLLED STUDY; DIAGONAL BAND OF BROCA; GABAERGIC SYSTEM; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MALE; MASS SPECTROMETRY; MEDULLA OBLONGATA; MESENCEPHALON; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OLFACTORY BULB; PONS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SUBTHALAMUS; THALAMUS;

ANIMALS; ASTROCYTES; BRAIN; BRAIN CHEMISTRY; CODEINE; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MORPHINE DERIVATIVES; NEURONS; PATCH-CLAMP TECHNIQUES;

EID: 79959700982     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22633     Document Type: Article

References (96)

1. Abraira VE, Hyun N, Tucker AF, Coling DE, Brown MC, Lu C, Hoffman GR, Goodrich LV. 2007. Changes in Sef levels influence auditory brainstem development and function. J Neurosci 27: 4273-4282.
2. Altman J, Das GD. 1965. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124: 319-335.
3. Arantes C, Nomizo R, Lopes MH, Hajj GN, Lima FR, Martins VR. 2009. Prion protein and its ligand stress inducible protein 1 regulate astrocyte development. Glia 57: 1439-1449.
4. Atmanene C, Laux A, Glattard E, Muller A, Schoentgen F, Metz-Boutigue MH, Aunis D, Van Dorsselaer A, Stefano GB, Sanglier-Cianferani S, Goumon Y. 2009. Characterization of human and bovine phosphatidylethanolamine-binding protein (PEBP/RKIP) interactions with morphine and morphine-glucuronides determined by noncovalent mass spectrometry. Med Sci Monit 15: BR178-187.
5. Bianchi E, Alessandrini C, Guarna M, Tagliamonte A. 1993. Endogenous codeine and morphine are stored in specific brain neurons. Brain Res 627: 210-215.
6. Bianchi E, Guarna M, Tagliamonte A. 1994. Immunocytochemical localization of endogenous codeine and morphine. Adv Neuroimmunol 4: 83-92.
7. Boettcher C, Fellermeier M, Boettcher C, Drager B, Zenk MH. 2005. How human neuroblastoma cells make morphine. Proc Natl Acad Sci U S A 102: 8495-8500.
8. Bourasset F, Cisternino S, Temsamani J, Scherrmann JM. 2003. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. J Neurochem 86: 1564-1567.
9. Brands A, Munzel PA, Bock KW. 2000. In situ hybridization studies of UDP-glucuronosyltransferase UGT1A6 expression in rat testis and brain. Biochem Pharmacol 59: 1441-1444.
10. Brix-Christensen V, Tonnesen E, Sanchez RG, Bilfinger TV, Stefano GB. 1997. Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response? Int J Cardiol 62: 191-197.
11. Brix-Christensen V, Goumon Y, Tonnesen E, Chew M, Bilfinger T, Stefano GB. 2000. Endogenous morphine is produced in response to cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand 44: 1204-1208.
12. Broadbelt KG, Paterson DS, Rivera KD, Trachtenberg FL, Kinney HC. 2010. Neuroanatomic relationships between the GABAergic and serotonergic systems in the developing human medulla. Auton Neurosci 154: 30-41.
13. Cameron HA, Woolley CS, McEwen BS, Gould E. 1993. Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience 56: 337-344.
14. Cardinale GJ, Donnerer J, Finck AD, Kantrowitz JD, Oka K, Spector S. 1987. Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sci 40: 301-306.
15. Coffman BL, Rios GR, King CD, Tephly TR. 1997. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25: 1-4.
16. Coller JK, Christrup LL, Somogyi AA. 2009. Role of active metabolites in the use of opioids. Eur J Clin Pharmacol 65: 121-139.
17. Ding YQ, Kaneko T, Nomura S, Mizuno N. 1996. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J Comp Neurol 367: 375-402.
18. Donnerer J, Cardinale G, Coffey J, Lisek CA, Jardine I, Spector S. 1987. Chemical characterization and regulation of endogenous morphine and codeine in the rat. J Pharmacol Exp Ther 242: 583-587.
19. Eisch AJ, Barrot M, Schad CA, Self DW, Nestler EJ. 2000. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A 97: 7579-7584.
20. Furuta T, Zhou L, Kaneko T. 2002. Preprodynorphin-, preproenkephalin-, preprotachykinin A- and preprotachykinin B-immunoreactive neurons in the accumbens nucleus and olfactory tubercle: double-immunofluorescence analysis. Neuroscience 114: 611-627.
21. Gintzler AR, Gershon MD, Spector S. 1978. A nonpeptide morphine-like compound: immunocytochemical localization in the mouse brain. Science 199: 447-448.
22. Gintzler AR, Levy A, Spector S. 1976. Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide, morphine-like compound in the central nervous system. Proc Natl Acad Sci U S A 73: 2132-2136.
23. Glattard E, Welters ID, Lavaux T, Muller A, Laux A, Zhang D, Schmidt AR, Delalande F, Lavantie BJ, Dirrig-Grosch S, Colin D, Van Dorsselaer A, Aunis D, Metz-Boutigue MH, Schneider F, Goumon Y. 2010. Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils. PLoS One 1: e8791.
24. Goldstein A, Barrett RW, James IF, Lowney LI, Weitz CJ, Knipmeyer LL, Rapoport H. 1985. Morphine and other opiates from beef brain and adrenal. Proc Natl Acad Sci U S A 82: 5203-5207.
25. Goumon Y, Bouret S, Casares F, Zhu W, Beauvillain JC, Stefano GB. 2000. Lipopolysaccharide increases endogenous morphine levels in rat brain. Neurosci Lett 293: 135-138.
26. Goumon Y, Angelone T, Schoentgen F, Chasserot-Golaz S, Almas B, Fukami MM, Langley K, Welters ID, Tota B, Aunis D, Metz-Boutigue MH. 2004. The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology. J Biol Chem 279: 13054-13064.
27. Goumon Y, Muller A, Glattard E, Marban C, Gasnier C, Strub JM, Chasserot-Golaz S, Rohr O, Stefano GB, Welters ID, Van Dorsselaer A, Schoentgen F, Aunis D, Metz-Boutigue MH. 2006. Identification of morphine-6-glucuronide in chromaffin cell secretory granules. J Biol Chem 281: 8082-8089.
28. Goumon Y, Laux A, Muller A, Aunis D. 2009. Central and peripheral endogenous morphine. An R Acad Nac Farm 75: 389-418.
29. Grobe N, Lamshoft M, Orth RG, Drager B, Kutchan TM, Zenk MH, Spiteller M. 2010. Urinary excretion of morphine and biosynthetic precursors in mice. Proc Natl Acad Sci U S A 107: 8147-8152.
30. Guarna M, Neri C, Petrioli F, Bianchi E. 1998. Potassium-induced release of endogenous morphine from rat brain slices. J Neurochem 70: 147-152.
31. Guarna M, Bianchi E, Bartolini A, Ghelardini C, Galeotti N, Bracci L, Neri C, Sonetti D, Stefano G. 2002. Endogenous morphine modulates acute thermonociception in mice. J Neurochem 80: 271-277.
32. Guarna M, Ghelardini C, Galeotti N, Bartolini A, Noli L, Neri C, Stefano GB, Bianchi E. 2004. Effects of endogenous morphine deprivation on memory retention of passive avoidance learning in mice. Int J Neuropsychopharmacol 7: 311-319.
33. Harburg GC, Hall FS, Harrist AV, Sora I, Uhl GR, Eisch AJ. 2007. Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons. Neuroscience 144: 77-87.
34. Hazum E, Sabatka JJ, Chang KJ, Brent DA, Findlay JW, Cuatrecasas P. 1981. Morphine in cow and human milk: could dietary morphine constitute a ligand for specific morphine (mu) receptors? Science 213: 1010-1012.
35. Hedou G, Chasserot-Golaz S, Kemmel V, Gobaille S, Roussel G, Artault JC, Andriamampandry C, Aunis D, Maitre M. 2000. Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or gamma-hydroxybutyrate in the rat substantia nigra and striatum. J Comp Neurol 426: 549-560.
36. Herbert RB, Venter H, Pos S. 2000. Do mammals make their own morphine? Nat Prod Rep 17: 317-322.
37. Hesse M. 2002. Alkaloid nature's curse or blessing? Zurich: Wiley-VCH Verlag.
38. Heurtaux T, Benani A, Moulin D, Muller N, Netter P, Minn A. 2006. Induction of UGT1A6 isoform by inflammatory conditions in rat astrocytes. Neuropharmacology 50: 317-328.
39. Hirrlinger J, Konig J, Dringen R. 2002. Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J Neurochem 82: 716-719.
40. Hirrlinger J, Moeller H, Kirchhoff F, Dringen R. 2005. Expression of multidrug resistance proteins (Mrps) in astrocytes of the mouse brain: a single cell RT-PCR study. Neurochem Res 30: 1237-1244.
41. Iversen L. 2006. Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 147(suppl 1): S82-88.
42. Jaeger CB. 1985. Cytoarchitectonics of substantia nigra grafts: a light and electron microscopic study of immunocytochemically identified dopaminergic neurons and fibrous astrocytes. J Comp Neurol 231: 121-135.
43. Kaplan MS, Bell DH. 1984. Mitotic neuroblasts in the 9-day-old and 11-month-old rodent hippocampus. J Neurosci 4: 1429-1441.
44. Kieffer BL, Gaveriaux-Ruff C. 2002. Exploring the opioid system by gene knockout. Prog Neurobiol 66: 285-306.
45. Koch M, Lingenhohl K, Pilz PK. 1992. Loss of the acoustic startle response following neurotoxic lesions of the caudal pontine reticular formation: possible role of giant neurons. Neuroscience 49: 617-625.
46. Kunkel GR, Mehrabian M, Martinson HG. 1981. Contact-site cross-linking agents. Mol Cell Biochem 34: 3-13.
47. Lee CS, Spector S. 1991. Changes of endogenous morphine and codeine contents in the fasting rat. J Pharmacol Exp Ther 257: 647-650.
48. Li CH, Chung D. 1976. Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc Natl Acad Sci U S A 73: 1145-1148.
49. Lin Y, Carpenter DO. 1994. Direct excitatory opiate effects mediated by non-synaptic actions on rat medial vestibular neurons. Eur J Pharmacol 262: 99-106.
50. Lotsch J. 2005a. Opioid metabolites. J Pain Symptom Manage 29(5 suppl): S10-24.
51. Lotsch J. 2005b. Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Symptom Manage 29(5 suppl): S90-103.
52. Lotsch J, Geisslinger G. 2001. Morphine-6-glucuronide: an analgesic of the future? Clin Pharmacokinet 40: 485-499.
53. Luskin MB. 1993. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 11: 173-189.
54. Mackenzie PI, Walter Bock K, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW. 2005. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15: 677-685.
55. Madbouly KM, Senagore AJ, Delaney CP. 2010. Endogenous morphine levels after laparoscopic versus open colectomy. Br J Surg 97: 759-764.
56. Mandyam CD, Norris RD, Eisch AJ. 2004. Chronic morphine induces premature mitosis of proliferating cells in the adult mouse subgranular zone. J Neurosci Res 76: 783-794.
57. Mansour A, Fox CA, Burke S, Akil H, Watson SJ. 1995. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 8: 283-305.
58. Martin-Ibanez R, Jenstad M, Berghuis P, Edwards RH, Hioki H, Kaneko T, Mulder J, Canals JM, Ernfors P, Chaudhry FA, Harkany T. 2006. Vesicular glutamate transporter 3 (VGLUT3) identifies spatially segregated excitatory terminals in the rat substantia nigra. Eur J Neurosci 23: 1063-1070.
59. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL. 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819-823.
60. Miller KK, Lupica CR. 1997. Neuropeptide FF inhibition of morphine effects in the rat hippocampus. Brain Res 750: 81-86.
61. Mizoguchi H, Tseng LF, Suzuki T, Sora I, Narita M. 2002. Differential mechanism of G-protein activation induced by endogenous mu-opioid peptides, endomorphin and beta-endorphin. Jpn J Pharmacol 89: 229-234.
62. Molina PE, Hashiguchi Y, Meijerink WJ, Naukam RJ, Boxer R, Abumrad NN. 1995. Modulation of endogenous opiate production: effect of fasting. Biochem Biophys Res Commun 207: 312-317.
63. Moron JA, Abul-Husn NS, Rozenfeld R, Dolios G, Wang R, Devi LA. 2007. Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol Cell Proteomics 6: 29-42.
64. Mrkusich EM, Kivell BM, Miller JH, Day DJ. 2004. Abundant expression of mu and delta opioid receptor mRNA and protein in the cerebellum of the fetal, neonatal, and adult rat. Brain Res Dev Brain Res 148: 213-222.
65. Muller A, Glattard E, Taleb O, Kemmel V, Laux A, Miehe M, Delalande F, G. R, Van Dorsselaer A, Metz-Boutigue MH, Aunis D, Goumon Y. 2008. Endogenous morphine in SH-SY5Y cells and the mouse cerebellum. PLoS One 3. Epub.
66. Nagano E, Yamada H, Oguri K. 2000. Characteristic glucuronidation pattern of physiologic concentration of morphine in rat brain. Life Sci 67: 2453-2464.
67. Neri C, Guarna M, Bianchi E, Sonetti D, Matteucci G, Stefano GB. 2004. Endogenous morphine and codeine in the brain of non human primate. Med Sci Monit 10: MS1-5.
68. Neri C, Ghelardini C, Sotak B, Palmiter RD, Guarna M, Stefano G, Bianchi E. 2008. Dopamine is necessary to endogenous morphine formation in mammalian brain in vivo. J Neurochem 106: 2337-2344.
69. Okura T, Saito M, Nakanishi M, Komiyama N, Fujii A, Yamada S, Kimura R. 2003. Different distribution of morphine and morphine-6 beta-glucuronide after intracerebroventricular injection in rats. Br J Pharmacol 140: 211-217.
70. Paxinos G, Franklin KBJ. 1997. The mouse brain in stereotaxic cooordinates. London: Elsevier Academic Press.
71. Persson AI, Thorlin T, Bull C, Eriksson PS. 2003a. Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors. Mol Cell Neurosci 23: 360-372.
72. Persson AI, Thorlin T, Bull C, Zarnegar P, Ekman R, Terenius L, Eriksson PS. 2003b. Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. Eur J Neurosci 17: 1159-1172.
73. Pert CB, Pasternak G, Snyder SH. 1973. Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182: 1359-1361.
74. Pierce TL, Wessendorf MW. 2000. Immunocytochemical mapping of endomorphin-2-immunoreactivity in rat brain. J Chem Neuroanat 18: 181-207.
75. Poeaknapo C, Schmidt J, Brandsch M, Drager B, Zenk MH. 2004. Endogenous formation of morphine in human cells. Proc Natl Acad Sci U S A 101: 14091-14096.
76. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T. 1994. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45: 330-334.
77. Reisine T. 1995. Opiate receptors. Neuropharmacology 34: 463-472.
78. Sargeant TJ, Day DJ, Mrkusich EM, Foo DF, Miller JH. 2007. Mu opioid receptors are expressed on radial glia but not migrating neuroblasts in the late embryonic mouse brain. Brain Res 1175: 28-38.
79. Soliman HM, Melot C, Vincent JL. 2001. Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth 87: 186-192.
80. Somogyi AA, Barratt DT, Coller JK. 2007. Pharmacogenetics of opioids. Clin Pharmacol Ther 81: 429-444.
81. Spector S, Kantrowitz JD, Oka K. 1985. Presence of endogenous morphine in toad skin. Prog Clin Biol Res 192: 329-332.
82. Stefano GB, Goumon Y, Casares F, Cadet P, Fricchione GL, Rialas C, Peter D, Sonetti D, Guarna M, Welters ID, Bianchi E. 2000. Endogenous morphine. Trends Neurosci 23: 436-442.
83. Stefano GB, Cadet P, Kream RM, Zhu W. 2008. The presence of endogenous morphine signaling in animals. Neurochem Res 33: 1933-1939.
84. Suleman FG, Abid A, Gradinaru D, Daval JL, Magdalou J, Minn A. 1998. Identification of the uridine diphosphate glucuronosyltransferase isoform UGT1A6 in rat brain and in primary cultures of neurons and astrocytes. Arch Biochem Biophys 358: 63-67.
85. Swerdlow NR, Caine SB, Geyer MA. 1991. Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat. Prog Neuropsychopharmacol Biol Psychiatry 15: 415-426.
86. Taguchi K, Suzuki Y. 1989. Effects of microiontophoretically-applied morphine on the Purkinje cell in the cerebellum of the cat. Neuropharmacology 28: 235-242.
87. Taguchi K, Abe K, Chyuma T, Kato M, Shigenaga T, Kushida K, Chikuma T. 2000. Effects of microiontophoretically-applied opioid peptides on Purkinje cells in the cat cerebellum. Acta Pharmacol Sin 21: 877-884.
88. Toll L, Berzetei-Gurske IP, Polgar WE, Brandt SR, Adapa ID, Rodriguez L, Schwartz RW, Haggart D, O'Brien A, White A, Kennedy JM, Craymer K, Farrington L, Auh JS. 1998. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. NIDA Res Monogr 178: 440-466.
89. Trescot AM, Datta S, Lee M, Hansen H. 2008. Opioid pharmacology. Pain Physician 11(2 suppl): S133-153.
90. von Bohlen Und Halbach O. 2007. Immunohistological markers for staging neurogenesis in adult hippocampus. Cell Tissue Res 329: 409-420.
91. Walker JF. 1964. Formaldehyde, 3rd ed. New York: Reinhold Publishing. p 486.
92. Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. 1986. Morphine and codeine from mammalian brain. Proc Natl Acad Sci U S A 83: 9784-9788.
93. Weitz CJ, Faull KF, Goldstein A. 1987. Synthesis of the skeleton of the morphine molecule by mammalian liver. Nature 330: 674-677.
94. Zadina JE, Hackler L, Ge LJ, Kastin AJ. 1997. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386: 499-502.
95. Zhang Y, Pan YX, Kolesnikov Y, Pasternak GW. 2006. Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variant mMOR-1B4 in the mouse central nervous system. Brain Res 1099: 33-43.
96. Zhu W, Bilfinger TV, Baggerman G, Goumon Y, Stefano GB. 2001. Presence of endogenous morphine and morphine 6 glucuronide in human heart tissue. Int J Mol Med 7: 419-422.